| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Chirag S Lalwani, Hamsini Movva, Sudheeran Kannoth, Vivek Nambiar, Siby Gopinath, Anandkumar Anandakuttan, Saraf U Umesh, Sreelakshmi Narayanan, Bijoy Jose, Annamma Mathai, Jyothi V Leelaman. Clinical Characteristics of Double Seropositive Myasthenia Gravis. Neurology India. vol 72. issue 5. 2024-10-21. PMID:39428782. |
double seropositive myasthenia gravis (dsp-mg) has antibodies positive to both acetylcholine receptor (achr) antibody and muscle-specific tyrosine kinase (musk) antibody. |
2024-10-21 |
2024-10-23 |
Not clear |
| Katherine D Mullen, Kathryn A Mozzochi, Mary J Hawkshaw, Robert T Satalof. Laryngeal Myasthenia Gravis in Voice Patients: Clinical, Serologic, and Neuromuscular Characterization of Seronegative Patients for Antibodies Against the Acetylcholine Receptor and Muscle-Specific Kinase. Journal of voice : official journal of the Voice Foundation. 2024-10-17. PMID:39419706. |
laryngeal myasthenia gravis (mg) is a focal manifestation of mg, and most patients are seronegative for antibodies against the acetylcholine receptor (achr) and muscle-specific kinase (musk). |
2024-10-17 |
2024-10-20 |
Not clear |
| Ali A Habib, Sabrina Sacconi, Giovanni Antonini, Elena Cortés-Vicente, Julian Grosskreutz, Zabeen K Mahuwala, Renato Mantegazza, Robert M Pascuzzi, Kimiaki Utsugisawa, John Vissing, Tuan Vu, Heinz Wiendl, Marion Boehnlein, Bernhard Greve, Franz Woltering, Vera Bri. Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study. Therapeutic advances in neurological disorders. vol 17. 2024-09-19. PMID:39297052. |
muscle-specific tyrosine kinase (musk) autoantibody-positive (ab+) generalised myasthenia gravis (gmg) is a rare and frequently severe subtype of gmg. |
2024-09-19 |
2024-09-21 |
Not clear |
| Julien Oury, Begona Gamallo-Lana, Leah Santana, Christophe Steyaert, Dana L E Vergoossen, Adam C Mar, Bernhardt Vankerckhoven, Karen Silence, Roeland Vanhauwaert, Maartje G Huijbers, Steven J Burde. Agonist antibody to MuSK protects mice from MuSK myasthenia gravis. Proceedings of the National Academy of Sciences of the United States of America. vol 121. issue 39. 2024-09-17. PMID:39288173. |
agonist antibody to musk protects mice from musk myasthenia gravis. |
2024-09-17 |
2024-09-20 |
mouse |
| Gregorio Spagni, Angela Vincent, Bo Sun, Silvia Falso, Leslie W Jacobson, Sean Devenish, Amelia Evoli, Valentina Damat. Serological Markers of Clinical Improvement in MuSK Myasthenia Gravis. Neurology(R) neuroimmunology & neuroinflammation. vol 11. issue 6. 2024-09-09. PMID:39250722. |
serological markers of clinical improvement in musk myasthenia gravis. |
2024-09-09 |
2024-09-13 |
Not clear |
| Xi Rong, Meijie Qu, Liwei Jiang, Min Li. A patient treated with ofatumumab for myasthenia gravis in conjunction with systemic lupus erythematosus and thyroid carcinoma. Intractable & rare diseases research. vol 13. issue 3. 2024-09-02. PMID:39220275. |
myasthenia gravis (mg) is an autoimmune disease mediated by b cells and is associated with acetylcholine receptor (achr) and muscle-specific receptor tyrosine kinase (musk) antibodies in the postsynaptic membrane at the neuromuscular junction. |
2024-09-02 |
2024-09-04 |
Not clear |
| Koya Tanaka, Masaaki Yoshikawa, Yukako Inoue, Keisuke Tsumura, Yuki Hoshino, Chika Shichijo, Toshihiro Ide, Kohei Suzuyama, Haruki Koik. Efgartigimod Successfully Ameliorated Acute Exacerbation of Myasthenia Gravis with Anti-muscle-specific Kinase Antibodies. Internal medicine (Tokyo, Japan). 2024-08-07. PMID:39111891. |
we herein report two patients with anti-muscle-specific kinase (musk) antibody-positive myasthenia gravis who experienced rapid deterioration of weakness, particularly respiratory muscle weakness, necessitating non-invasive positive pressure ventilation (nippv) and were treated with efgartigimod. |
2024-08-07 |
2024-08-10 |
Not clear |
| Berin Inan, Irem Gul Orhan, Can Ebru Bekircan-Kurt, Sevim Erdem-Ozdamar, Ersin Ta. Clinical and laboratory remission with rituximab in anti-MuSK-positive myasthenia gravis. Irish journal of medical science. 2024-08-01. PMID:39088160. |
increasing data are available on the use and efficacy of rituximab (rtx) in patients with anti-muscle-specific tyrosine kinase (musk)-positive myasthenia gravis (mg), especially those steroid-dependent or unresponsive to traditional immunotherapies. |
2024-08-01 |
2024-08-03 |
Not clear |
| Silvia Falso, Marco Gessi, Sofia Marini, Roberta Benvenuto, Eleonora Sabatelli, Antonio D'Amati, Martina Marini, Amelia Evoli, Raffaele Iori. Cancer Frequency in MuSK Myasthenia Gravis and Histological Evidence of Paraneoplastic Etiology. Annals of neurology. 2024-07-15. PMID:39007444. |
cancer frequency in musk myasthenia gravis and histological evidence of paraneoplastic etiology. |
2024-07-15 |
2024-07-18 |
Not clear |
| Silvia Falso, Marco Gessi, Sofia Marini, Roberta Benvenuto, Eleonora Sabatelli, Antonio D'Amati, Martina Marini, Amelia Evoli, Raffaele Iori. Cancer Frequency in MuSK Myasthenia Gravis and Histological Evidence of Paraneoplastic Etiology. Annals of neurology. 2024-07-15. PMID:39007444. |
cancer frequency in muscle-specific kinase myasthenia gravis (musk-mg) has not yet been explored and the mechanisms leading to the formation of musk igg remain elusive. |
2024-07-15 |
2024-07-18 |
Not clear |
| Dinusha Gayathri, Shanika Nandasiri, Gamini Pathiran. A Case Report of MuSK Antibody-Positive Myasthenia Gravis. Cureus. vol 16. issue 6. 2024-07-08. PMID:38975540. |
a case report of musk antibody-positive myasthenia gravis. |
2024-07-08 |
2024-07-11 |
Not clear |
| Dinusha Gayathri, Shanika Nandasiri, Gamini Pathiran. A Case Report of MuSK Antibody-Positive Myasthenia Gravis. Cureus. vol 16. issue 6. 2024-07-08. PMID:38975540. |
however, a minority of patients have antibodies against muscle-specific tyrosine kinase (musk), which is referred to as musk myasthenia gravis (musk-mg). |
2024-07-08 |
2024-07-11 |
Not clear |
| Geke Zhu, Yongbo Ma, Han Zhou, Xiangtao Nie, Wenjing Qi, Lei Hao, Xiuming Gu. Case report: Rapid clinical improvement in acute exacerbation of MuSK-MG with efgartigimod. Frontiers in immunology. vol 15. 2024-06-24. PMID:38911858. |
myasthenia gravis with positive musk antibody often involves the bulbar muscles and is usually refractory to acetylcholinesterase inhibitors. |
2024-06-24 |
2024-06-26 |
Not clear |
| Chi Ma, Dan Liu, Benqiao Wang, Yingying Yang, Ruixia Zh. Advancements and prospects of novel biologicals for myasthenia gravis: toward personalized treatment based on autoantibody specificities. Frontiers in pharmacology. vol 15. 2024-06-17. PMID:38881870. |
autoantibodies include long-lived antibodies against the acetylcholine receptor (achr), mainly of the igg1 subclass, and igg4, produced almost exclusively by short-lived plasmablasts, which are prevalent in muscle-specific tyrosine kinase (musk) myasthenia gravis. |
2024-06-17 |
2024-06-19 |
Not clear |
| Shreya Jaiswal, Tripti Shrivastav. Advances in Understanding and Managing Myasthenia Gravis: Current Trends and Future Directions. Cureus. vol 16. issue 4. 2024-05-29. PMID:38803727. |
myasthenia gravis (mg) is an autoimmune illness characterized by autoantibodies against the acetylcholine receptor (achr), muscle-specific tyrosine kinase (musk), and an increasing number of extra postsynaptic proteins. |
2024-05-29 |
2024-06-03 |
Not clear |
| Shreyashi Jha, Santosh Kumar Pendyal. MuSK Antibody-Positive Myasthenia Gravis With SARS CoV-2 Infection: A Case Report and Literature Review. Journal of clinical neuromuscular disease. vol 25. issue 4. 2024-05-21. PMID:38771234. |
musk antibody-positive myasthenia gravis with sars cov-2 infection: a case report and literature review. |
2024-05-21 |
2024-05-27 |
Not clear |
| R Ricciardi, E Latini, M Guida, I Koneczny, M Lucchi, M Maestri, A De Rosa, A Vincen. Acetylcholinesterase inhibitors are ineffective in MuSK-antibody positive myasthenia gravis: Results of a study on 202 patients. Journal of the neurological sciences. vol 461. 2024-05-17. PMID:38759248. |
myasthenia gravis (mg) with musk antibodies (musk-mg) represents a distinct subtype with different responses to treatments compared to patients with achr antibodies, especially in terms of tolerance to acetylcholinesterase inhibitors (achei). |
2024-05-17 |
2024-05-27 |
Not clear |
| Masakatsu Motomura, Hiroko Kitanosono, Shunsuke Yoshimura, Hirokazu Shiraish. [Muscle-Specific Receptor Tyrosine Kinase Antibody Positive Myasthenia Gravis]. Brain and nerve = Shinkei kenkyu no shinpo. vol 76. issue 5. 2024-05-14. PMID:38741505. |
reportedly, patients with muscle-specific kinase (musk) antibody-positive myasthenia gravis (mg) account for approximately 3.0% of all patients with mg in japan. |
2024-05-14 |
2024-05-27 |
Not clear |
| Inga Koneczny, Marina Mané-Damas, Shenghua Zong, Sander De Haas, Saif Huda, Daan van Kruining, Jan Damoiseaux, Anna De Rosa, Michelangelo Maestri, Melania Guida, Peter Molenaar, Philip Van Damme, Andreas Fichtenbaum, Thomas Perkmann, Marc De Baets, Konstantinos Lazaridis, Vasiliki Zouvelou, Socrates Tzartos, Roberta Ricciardi, Mario Losen, Pilar Martinez-Martine. A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression. Frontiers in immunology. vol 15. 2024-05-08. PMID:38715598. |
a retrospective multicenter study on clinical and serological parameters in patients with musk myasthenia gravis with and without general immunosuppression. |
2024-05-08 |
2024-05-27 |
Not clear |
| Inga Koneczny, Marina Mané-Damas, Shenghua Zong, Sander De Haas, Saif Huda, Daan van Kruining, Jan Damoiseaux, Anna De Rosa, Michelangelo Maestri, Melania Guida, Peter Molenaar, Philip Van Damme, Andreas Fichtenbaum, Thomas Perkmann, Marc De Baets, Konstantinos Lazaridis, Vasiliki Zouvelou, Socrates Tzartos, Roberta Ricciardi, Mario Losen, Pilar Martinez-Martine. A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression. Frontiers in immunology. vol 15. 2024-05-08. PMID:38715598. |
muscle-specific kinase (musk)- myasthenia gravis (mg) is caused by pathogenic autoantibodies against musk that correlate with disease severity and are predominantly of the igg4 subclass. |
2024-05-08 |
2024-05-27 |
Not clear |